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ABSTRACT: Mycoplasma hyopneumoniae is cultured on large-scale
to produce antigen for inactivated whole-cell vaccines against
respiratory disease in pigs. However, the fastidious nutrient require-
ments of this minimal bacterium and the low growth rate make it
challenging to reach sufﬁcient biomass yield for antigen production. In
this study, we sequenced the genome of M. hyopneumoniae strain 11
and constructed a high quality constraint-based genome-scale
metabolic model of 284 chemical reactions and 298 metabolites.
We validated themodel with time-series data of duplicate fermentation
cultures to aim for an integratedmodel describing the dynamic proﬁles
measured in fermentations. The model predicted that 84% of cellular
energy in a standardM. hyopneumoniae cultivation was used for non-
growth associated maintenance and only 16% of cellular energy was
used for growth and growth associated maintenance. Following a cycle
of model-driven experimentation in dedicated fermentation experi-
ments, we were able to increase the fraction of cellular energy used for
growth throughpyruvate addition to themedium. This increase in turn
led to an increase in growth rate and a 2.3 times increase in the total
biomass concentration reached after 3–4 days of fermentation,
enhancing the productivity of the overall process. Themodel presented
provides a solid basis to understand and further improve M.
hyopneumoniae fermentation processes.
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Introduction
M. hyopneumoniae causes enzootic pneumoniae in pigs. Multiple
vaccines are available that provide protection against
M. hyopneumoniae infection; all contain the inactivated whole-
cell bacterium as active component. Manufacturing of these
vaccines is done in large-scale fermenter systems in which a
sufﬁciently high biomass concentration should be reached to meet
production requirements. However, reaching sufﬁciently high
biomass concentrations in M. hyopneumoniae fermentations is
challenging due to the fastidious growth requirements of this
organism, which remain largely unknown.
Only for a small number of mycoplasma species a chemically
deﬁned medium enabling growth is available (Rodwell, 1969;
Tourtelotte et al., 1964; Yus et al., 2009). As a result, growth media
for production of mycoplasma vaccines are undeﬁned and often
contain components from animal origin for which the exact
chemical composition is not known such as serum or animal-
derived peptones. Moreover, the concentration of critical compo-
nents such as glucose, lipids and vitamins, varies largely thus
challenging the development of a robust production process. In
addition, the intrinsic growth rates of mycoplasma species are often
low and possibly related to limitations in protein biosynthesis
capacity (Yus et al., 2009), which poses an additional hurdle for the
production process.
A constraint-based metabolic model (CBM) provides a list of
biochemical reactions, describes the network topology of metabolic
pathways and provides a modeling framework to predict and
understand biological processes (Thiele and Palsson, 2010).
Haemophilus inﬂuenzae (Schilling and Palsson, 2000) was the ﬁrst
bacterium for which a CBM was made and since then >400
genome-scale metabolic reconstructions have been made available
for the scientiﬁc community via the Biomodels database (Juty et al.,
2015). Considerable efforts have been made to model various
mycoplasma species: M. genitalium (Suthers et al., 2009),
M. gallisepticum (Bautista et al., 2013), M. pneumoniae (Wodke
et al., 2013), and M. hyopneumoniae and other swine pathogens
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(Ferrarini et al., 2016). These models show in general that the
inferred metabolic networks are small compared to other bacteria,
linear and have a low redundancy (Yus et al., 2009), which is
expected in bacteria with a minimal genome.
CBMs are routinely applied to optimize ﬂux through a chosen
reaction and to analyze ﬂux distributions that support this minimal
or maximal ﬂux given the measured constraints related to substrate
uptake or by-product formation. Most often, the selected reaction is
biomass formation as ﬂux through the biomass reaction represents
the organism’s growth rate. Accurate growth rate predictions
require detailed knowledge of the chemical composition of biomass.
The biomass composition has been determined for M. pneumoniae
(Wodke et al., 2013), which can be grown on deﬁned medium, but it
is a challenge to determine the biomass composition for species that
cannot be cultured on deﬁned media.
In this study, we developed and deployed a CBM to explore,
speciﬁcally, energy metabolism. Our goal was to understand and
improve a fermentation process used for commercial production of
a M. hyopneumoniae vaccine. We validated the model with
dedicated fermentor experiments in which we measured metabolite
proﬁles and determined gene expression using RNA sequencing. We
used the model to improve aerobic fermentation cultures on
complex FRIIS medium thereby showing the potential of our
modeling framework for further optimization ofM. hyopneumoniae
vaccine production processes.
Materials and Methods
Strain Cultivation and Genome and Transcriptome
Sequencing
M. hyopneumoniae strain 11 cultures were grown using FRIIS
medium (Friis, 1975) to which 1.5 g/l glucose was added or in
medium to which 1.5 g/l glucose and 2.2 g/l sodium pyruvate was
added. Sartorius Stedim Biostat fermentor systems were used with a
maximum capacity of 2.0 L. The pH set-point was controlled at 7.4
using only caustic soda (NaOH, 4N), temperature was controlled at
37C and the dissolved oxygen concentration was controlled at 5%
oxygen saturation using a stirrer speed cascade. Fermentation runs
took on average 3–4 days during which 11–14 samples were
withdrawn for metabolite and biomass analysis. A ﬂow cytometer
(FACSMicroCount, BD) was used to determine the total cell count
and based on the titer the biomass concentration was calculated
assuming an average cell mass of 0.074 pg/cell (Rosengarten et al.,
1988). For genome sequencing, DNAwas extracted from a bacterial
pellet using the Gentra Puregene bacterial kit (Qiagen, GmbH,
Hilden, Germany). A standardized method (supplementary
materials) was used to sequence and assemble the genome using
Illumina HiSeq sequencing (paired-end, 50 cycles, 500mb, 50 bp
read length) and PacBio sequencing (1 SMRT cell, 60mb). RNAwas
extracted from bacterial pellets using the Qiagen RNeasy mini kit.
RNAwas sequencedusing IlluminaHiSeq (single-end reads, half a lane
per sample, 50 cycles) using a standardized method (supplementary
materials). Gene expression was analyzed using the R Bioconductor
package SCAN_UPC (Piccolo et al., 2012). Changes in expression levels
per gene were estimated by comparison of RPKM values (Reads Per
Kilobase per Million mapped reads). Raw data of genome sequencing
and RNA sequencing was deposited in the NCBI Short Read Archive
(SRP101540 and SRP053697).
Metabolite Analysis Using HPLC
Glycerol, glucose, fructose, mannose, myo-inositol, and ribose were
quantiﬁed in culture supernatant using an ion chromatograph
ICS-3000 system with a Dionex CarboPac MA1 (250 4.0mm)
column. Injection volume was 5mL; eluents used were 100mM
NaOH and 5mM NaOH. Lactate, acetate, formate and pyruvate were
determined using the same HPLC system but ﬁtted with a Dionex
IonPac AS-11-HC column (250 4.0mm) with a 5mL injection
volume and three eluents: 100mMNaOH, 5mMNaOH, and puriﬁed
water. Each fermentation sample was measured once per method.
Genome Annotation
The genome was annotated using the SAPP annotation pipeline,
(Koehorst et al., 2016a). For gene prediction Prodigal version 2.6.2
(Hyatt et al., 2010) with codon table 4 was used. Protein annotation
was done using InterProScan version 5.17–56.0 (Jones et al., 2014)
as previously described (Kamminga et al., 2017).
Construction Genome-Scale Metabolic Model
The annotated genome sequence was imported into Pathway tools
(Karp et al., 2016). The PathoLogic tool v. 17.0 was used to create a
draft metabolic map (Fig. 1 and supplementary methods),
speciﬁcally the modules to assign possible enzymatic reactions,
protein complexes and to predict presence or absence of metabolic
pathways (Karp et al., 2011). Manual curation (supplementary
materials) was performed using a decision scheme based on the
presence or absence of functional protein domains and comparison
to annotated genes in the M. hyopneumoniae reference genomes
(strains: 232, J, 168, 168L, 7422, and 7448) and to the gene content
of theM. pneumoniaemetabolic model (Wodke et al., 2013). In line
with previous studies (Pollack, 2002; Yus et al., 2009), we assumed
broad substrate speciﬁcity for a number of enzymes in nucleotide
metabolism. For instance, pyruvate kinase and the 50-nucleotidase
were assumed to function with 8 nucleotide diphosphates as
substrate. The entire Pathway Tools database was exported to ﬂat
ﬁles and with a BASH script converted to SBML. Cobrapy v0.2.1
(Ebrahim et al., 2013) was used to create a SBML version
compatible with MATLAB v.R2016b and the Cobra Toolbox v.2.0.6
(Schellenberger et al., 2011) with LibSBML v.5.13.0 package
enabled (Bornstein et al., 2008). Molecular formulas were added for
macro-molecules and cellular components when needed (supple-
mentary materials). Additionally, transport reactions were added
for all amino acids, nucleotides, vitamins, fatty acids, phosphati-
dylcholine, and general metabolic inputs and by-products for which
no annotated transporter existed.
Constraint-Based Modeling
Reactions in the model were represented as a matrix describing
reaction substrates, products and their stoichiometries (Orth
et al., 2010). We assumed biomass consisted of: 62% protein, 20%
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lipids, 5% DNA, 6.5% RNA, 1.5% free amino acids, and 0.1% acyl
carrier protein (cofactors and vitamins were not included) (Razin
et al., 1963; Wodke et al., 2013). Bounds were set for the reaction
rates to represent reaction directionality. For several reactions
(glucose, glycerol, and glycerol-3-phosphate uptake, Table S1), the
bounds were set to match physiologically known constraints.
Protein and RNA degradation were simulated by imposing
positive lower bounds to the protein and RNA degradation
reactions; values were taken from the M. pneumoniae model
(Wodke et al., 2013). Flux balance analysis (FBA) was used to
maximize the ﬂux towards the chosen objective reaction,
assuming a steady-state system which mimics exponential
growth and to identify combinations of ﬂuxes supporting this
maximal ﬂux using the Cobra Toolbox v.2.0.6 and Gurobi solver
v.6.5.2 (Gurobi Optimization, Houston, TX). Gene essentiality was
assessed by setting the reaction rate(s) coupled to a gene of
interest to zero and analyzing if the model still supported growth;
that is if the model supported ﬂux through the biomass synthesis
reaction. Alternative ﬂux distributions were identiﬁed through
ﬂux variability analysis (Mahadevan and Schilling, 2003). Brieﬂy,
the maximum value for the objective function was calculated; a
new constraint was set for the objective function, so that the ﬂux
remains higher than 99.99% (or 99.9% in the second run) of the
original value; subsequently each reaction in the model was set as
objective function of two FBA rounds maximizing and
minimizing the corresponding reaction. The model was deposited
in the BioModels database (Chelliah et al., 2015) and assigned the
identiﬁer MODEL1704250001.
Dynamic Model
Differential equations (supplementary materials) were used to
model glucose, lactate, glycerol, oxygen, and pyruvate transport
using ﬁrst-order Michaelis–Menten kinetics (Hjersted and
Henson, 2006). Kinetic parameters were obtained from
M. mycoides (Miles et al., 1985), M. pneumoniae (Wodke
et al., 2013) or from batch data of M. hyopneumoniae
fermentations (Fig. 1). Time proﬁles for bacterial cultivations
were simulated by combining the set of dynamic equations and
the genome-scale metabolic model. The initial substrate, biomass
and by-product concentrations were used to calculate the growth
rate, substrate and by-product consumption/production rates at
t¼ 0 h. With the set of differential equations the changes in
substrate and by-product concentrations were calculated using
the ode45 solver in MATLAB v.R2016b. In each iterative cycle, the
genome-scale model was used to re-calculate the growth rate and
substrate and by-product consumption/production rates (Varma
and Palsson, 1994). Oxygen concentration in the liquid phase was
ﬁtted using a second order polynomial equation derived from the
experimental data (Fig. S1).
Results
M. hyopneumoniae Strain 11 Genome Sequencing and
Comparison to Published Genomes
Genome assembly including scaffolding and gap-ﬁlling resulted in a
genome sequence of length 898,877 base-pairs (bp), consisting of 5
scaffolds, of lengths 341707, 244821, 176273, 32027, and 4049 bp,
with an average GC content of 28.6% (NCBI accession number
MWWN00000000). We identiﬁed 681 protein coding sequences,
466 proteins with at least one protein domain, 855 unique protein
domains, and 77 EC numbers using InterProScan (Table I). The
genome of strain 11 was compared to the currently published
M. hyopneumoniae genomes (strains: 232, J, 168L, 168, 7422, and
7448) based on the protein domain repertoire (Kamminga et al.,
2017; Koehorst et al., 2016b). We identiﬁed a pan-domainome size
of 866 protein domains, of which 846 (98%) were present in all
strains (core domainome). We conclude from this comparative
analysis that the metabolic capabilities ofM. hyopneumoniae strains
were predicted to be highly similar, as was also found by Ferrarini
et al. (Ferrarini et al., 2016).
Fig 1. Creation and application of a dynamic flux balance model. Steps needed to create the dynamic model from the annotated genome of M. hyopneumoniae. Kinetic
parameters were obtained from M. pneumoniae (a) (Wodke et al., 2013), M. mycoides (b) (Miles et al., 1985) or fitted from M. hypneumoniae HPLC data (c).
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Genome-Scale Metabolic Model
Based on the genome sequence of M. hyopneumoniae strain 11, we
created a CBM which consisted of 284 reactions and 298
metabolites (Table II, Fig. 2). The model was termed
TK284-MHyo11. On average, the number of reactions catalyzed
per enzyme was 1.39 1.05; this value is close to other bacteria
with a low number of protein coding genes (Yus et al., 2009).
Analysis of RNA seq. data using SCAN_UPC (Piccolo et al., 2012,
2013) showed that the genes encoding enzymes underlying the
reactions in the model were expressed under aerobic conditions on
FRIIS medium (Fig. S2).
Comparison to Existing Mycoplasma Models
The number of reactions in our model was lower than the number
found in the model of M. pneumoniae or the reference model of
M. hyopneumoniae (encompassing 306 and 426 reactions,
respectively, Table II). The functional annotation of our model on
the other hand was compared to the reference model of
M. hyopneumoniae strain 232 and was found to be better aligned
with the genome information as it contained less (orphan) reactions
unlinked to genome encoded functions. This was a direct result of the
approach used during manual curation, where we assigned
functionality based on the presence of protein domains associated
to a metabolic reaction and, in general, only added reactions for
which associated protein domainswhere found in the genome, which
resulted in a reduction in the number of orphan reactions. For
example, we did not ﬁnd protein domains related to fumarate
production, succinate production, folate metabolism, phosphatidyl-
choline synthesis, and synthesis of glycolipids and therefore did not
incorporate these reactions in our model although they were present
in the reference model as orphan reactions. Interestingly, in the
reference model of M. hyopneumoniae strain 232 there was no
annotated gene for alcohol dehydrogenase (EC 1.1.1.1), while other
M. hyopneumoniae strains did have this functionality annotated. In
strain 11 we did not ﬁnd a gene for alcohol dehydrogenase either.
Comparison of our M. hyopneumoniae metabolic model to the
M. pneumoniaemetabolic model showed notable differences such as
the presence (in our model) of a myo-inositol degradation pathway,
the presence of a N-acetyl-D-glucosamine degradation pathway and a
likely absence of folate metabolism as only a single gene related to
folatemetabolism could be found in the strain 11 genome: EC 2.1.2.1:
glycine hydroxymethyltransferase. Also absent in our model when
compared to M. pneumoniae were alcohol dehydrogenase, arginine
fermentation, glycolipid metabolism, and thymidylate synthase.
Parameterization and Validation
Wemeasured the initial substrate concentrations in several medium
lots to determine starting concentrations of metabolites (Table S2).
Table II. Model characteristics.
Model
Model characteristic TK284-MHyo11 M. hyopneumoniae 232 M. pneumoniae M129
Total reactions 284a 426 306
Number of genes in the model 133 170 145
Number of gene-protein reactions (GPR’s)b 185 233 197
Orphan reactionsc 82a 97 92
Exchange reactionsd 52 97 57
Transport reactions 53 111 75
Metabolites 298 397 266
aExcluded were 9 conversion reactions from mol to gram.
bNumber of gene protein reactions¼ number of reactions with an associated gene.
cOrphan reactions¼ reactions without an associated gene, not including exchange reactions
dExchange reactions¼ reactions needed to exchange consumed or secreted compounds.
Table I. M. hyopneumoniae genome characteristics.
Strain Genome size (bp) Total amount of proteinsa Proteins with domainsb Total unique domainsc Total unique EC#sd
11 898877 681 466 855 77
232 892758 681 468 856 78
J 897405 692 479 859 78
168 925576 698 470 857 78
168L 921093 700 471 857 78
7422 898495 703 477 857 78
7448 920079 690 476 862 78
aAmount of proteins based on prodigal gene calling.
bNumber of proteins which contain at least one protein domain.
cNumber of unique domains annotated by InterProScan.
dNumber of unique EC numbers annotated by InterProScan.
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The average growth rate reached in FRIIS medium was 0.0177 h1
(duplicate batches 0.0219 and 0.0135 h1, respectively). Part of the
growth rate variation between batches is most likely caused by
variations in the medium composition due to the use of components
from animal origin. For initial model simulations the only carbon
sources for which consumption was allowed were glucose, glycerol
and glycerol-3-phosphate. We had no analytical method to measure
glycerol-3-phosphate in the medium and therefore copied the
consumption rate for this compound from the M. pneumoniae
model. Additionally, we allowed in silico consumption of other
Fig. 2. Metabolic map of M. hyopneumoniae. Pathways are indicated by background color: glycolysis (blue), alternative sugar metabolism (purple), lipid metabolism (green),
vitamin and co-factor metabolism (orange), nucleotide metabolism (yellow), Pentose Phosphate Pathway (PPP) (red), and amino acid metabolism (blue). Pathways highlighted in red
are absent from M. pneumoniae. Abbreviations are explained in Table S11.
Kamminga et al.: Mycoplasma hyopneumoniae Metabolic Modeling 5
Biotechnology and Bioengineering
components such as amino acids, nucleotides and lipids as listed in
Table S3. We used the CBM to estimate (and subsequently ﬁx in the
model) an energy expenditure of 18.4 mmol  gDW1  h1 as non-
growth associated maintenance rate (NGAM). The NGAM was
estimated by adding a non-speciﬁc energy consumption reaction to
the model. The lower limit of this reaction was then gradually
increased until agreement was found between the measured and the
model predicted growth rate.
The parameterized CBM was used to build the integrated
dynamic model, which was validated by simulation of time proﬁles
in aerobic fermentor cultures. We assumed glycerol to be a non-
limiting component in these cultures since it could be obtained
from complex medium components. Based on oxygen consumption
proﬁles we calculated an average lag-phase of 12.5 h for the
duplicate fermentation cultures and started model simulations with
a biomass concentration of 5.89  103 gDW  l1. Measured
biomass and glucose concentrations were in agreement with
predicted values (Fig. 3A and B). The predicted acetate
concentration was slightly lower than measured (Fig. 3C),
indicating possible consumption of additional carbon sources
from the complex medium.
Analysis of In Silico Flux Distributions and Energy
Balances
Up to 124 enzymatic and transport reactions were able to carry
ﬂux while growing on glucose and glycerol under aerobic
conditions, 44% of the total amount of reactions in the model
(excluding conversion reactions, Table II). NGAM required 84.2%
of total cellular energy, 0.9% was used for growth-associated
maintenance and 14.9% for reactions needed for growth (Fig. 3D,
Table S4). In M. pneumoniae cultures 71–88% of cellular energy
was used for NGAM and 12–29% for growth, depending on the
culture stage (Wodke et al., 2013). Among the growth related
functions, the ones consuming the most energy were protein
production, RNA production and protein degradation (Fig. 3E).
Energetic costs of DNA production were negligible compared to
these other categories. When compared to the growth related
energy sinks in M. pneumoniae, our model did not contain
protein folding as energy sink and had reduced lipid synthesis
capability.
Flux Variability Analysis and Gene Essentiality Analysis
We performed ﬂux variability analysis to explore alternative
ﬂux distributions compatible with at least 99.99% of the
maximal growth rate. The majority of the reactions showed
negligible variability as was also found for M. pneumoniae
(Wodke et al., 2013). We identiﬁed the 20 reactions that showed
the largest ﬂux change (Table S5). All these reactions were
related to conversion of purine nucleotides; there was some
ﬂexibility in the network which allowed for alternative pathways
to produce dADP and dGDP (Fig. 2). Reaction directionality
was changed for the reactions catalyzed by phosphoglycerate
kinase which conﬁrmed that the ﬂexible substrate use assumed
for this enzyme improved network ﬂexibility. We also
performed ﬂux variability analysis allowing 0.1% (Table S6)
variation in the growth rate and we identiﬁed additional
reactions for which directionality changed: CMP kinase and the
asparagine-tRNA ligase. For the latter function there were two
separate reactions in the model, one irreversible and one
reversible reaction which provided ﬂexibility in the network
and allowed the direction change for the reversible reaction.
Finally, gene essentiality analysis showed that 41% of genes in
the model were classiﬁed as essential for growth (Table S7).
There is currently insufﬁcient experimental information on
gene essentiality in M. hyopneumoniae to validate this result
(Maglennon et al., 2013).
Fig. 3. Metabolite profiles and energy balances in standardM. hyopneumoniae fermentations. Comparison of model predicted aerobic batch profiles (dashed line) to measured
profiles in fermentation batches (N¼ 2, dots and pyramids) for: (A) biomass, (B) glucose, (C) acetate concentration, (D) distribution of energy consumption, and (E) major growth
related energy consumption.
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Model Predicts That Pyruvate Addition Increases the
Growth Rate
As was also observed inM. pneumoniae, the metabolic pathway that
carried the largest amount of ﬂux was glycolysis and pyruvate
metabolism. Pyruvate has been mentioned in literature to increase
the growth rate of mycoplasma species (Miles et al., 1988). We
conﬁrmed that in our model pyruvate addition increases growth rate
and ran dedicated fermentor studies to assess the effect on growth
and metabolite proﬁles (Fig. 4A–E). Interestingly, we observed
production of lactate under aerobic conditions (Fig. 4D) which is
energetically unfavorable. Three metabolic scenarios were simulated
with the dynamic integrated model: (i) growth on pyruvate with
lactate production and a lowered biomass speciﬁc glucose uptake
rate; (ii) growth on glucose and pyruvate; and (iii) growth on lactate,
glucose and pyruvate. In the initial metabolic condition the ﬂux
through the PEP-PTS transporter for glucose was assumed to be
lower as a result of product inhibition. The previously ﬁtted NGAM
rate was too high to support growth in the initial metabolic condition
when cells were growing on pyruvate and glucose. The growth rate
measured in the initial stage of the culture was compatible with a
decreased NGAM rate of 10.15mmol ATP  gDW1  h1. Based on
measured metabolite proﬁles we increased the ﬂux through the
glucose transporter when the pyruvate concentration was less than
2.7mM. This had a positive inﬂuence on the growth rate (Fig. 4A).
Near the time of pyruvate exhaustion in the medium, lactate is
consumed and growth-rate further increases. In our simulation, the
culture reached stationary phase when a biomass concentration of
0.05 gDW  l1 was reached according to measured biomass data.
Energy balances at early and late (t¼ 45 h) exponential growth
showed that in the simulations with pyruvate addition, a higher
fraction of energy was allocated to growth (Fig. 4F).
Strain Design
The model was used to study the impact of gene knock-in mutants
on growth assuming growth on FRIIS medium with only glucose
added. Our model includes a complete myo-inositol consumption
pathway which was absent in other mycoplasma species. We did not
observe consumption of this component in aerobic fermentor
studies and in our model the myo-inositol transporter is an orphan
reaction as there was no annotated transporter. A M. hyopneumo-
niae mutant with a knock-in of a myo-inositol permease should be
able to consume myo-inositol from the growth medium, for such a
mutant the model predicted a doubling of the growth rate (from
0.0177 to 0.0352 h1) upon consumption of 0.25mmol myo-
inositol  gDW1  h1 (Table S8). If a knock-in with an ABC
transporter for myo-inositol is done, the ATP demands of the
transporter would enable a slightly lower growth rate (0.0308 h1).
An even more challenging knock-in would be the expression of the
complete pathway for arginine fermentation, which is absent in M.
hyopneumoniae. In M. pneumoniae this pathway consists of ﬁve
genes (MPN304-307 and MPN560) coupled to three reactions.
Simulation of a knock-in with the ﬁveM. pneumoniae genes and an
additional transporter for one of the by-products L-ornithine leads
to an increased in silico mutant growth rate of 0.0235 h1
(Table S8), as long as arginine consumption is allowed with the
same ﬂux as determined in M. pneumoniae.
Discussion
We have developed and applied a CBM of M. hyopneumoniae
strain 11 to study and improve biomass yield in fermenter
systems. Our aim was to understand cellular energy balances
during growth and ﬁnd methods to increase biomass yield. We
found that in the standard cultivation medium used for
M. hyopneumoniae, 84% of total ATP production by the cell is
used for non-growth associated maintenance and only 14.9% is used
for growth. This conﬁrms the results found in M. pneumoniae.
A possible explanation for the high percentage of energy used for
NGAM could be the high surface-to-volume ratio of mycoplasma
species which means that maintaining cellular homeostasis is
energetically expensive (Wodke et al., 2013).
Fig. 4. Pyruvate supplementation increases total biomass yield and results in lactate production under aerobic conditions. Comparison of model predicted aerobic batch profiles
(dashed line) to measured profiles in fermentation batches (N¼ 2, dots and pyramids) after pyruvate supplementation to medium for: (A) biomass, dotted grey lines indicate variation
in the final concentration of biomass reached, (B) glucose, (C) pyruvate, (D) lactate, (E) acetate concentration, and (F) energy distribution early stage (top) and at t¼ 45h.
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Because our focus for modeling was mainly on understanding
cellular energy balances we used a simpliﬁed biomass composition
in the model. We calculated ATP consumption of reactions related to
vitamin and cofactor metabolism in the M. pneumoniaemodel and
found that these reactions consumed only 0.003% of total cellular
energy (Table S9). This shows that strictly for understanding the
cellular energy distribution, the contribution of reactions in
co-factor and vitamin production can be neglected. Moreover, it
remains unclear which of these components are consumed directly
from the complex medium and which are produced by the
bacterium. Our CBM also lacked almost all reactions related to
folate metabolism although this component is generally assumed to
be essential for growth because formylation of initiator methionyl-
tRNA is needed to start translation in bacteria (de Crecy-Lagard
et al., 2007). However, because formylation of methionyl-tRNA does
not occur in Pseudomonas aeruginosa (Newton et al., 1999) and is
also not described as part of the minimal bacterial gene set (Gil
et al., 2004), we ﬁnd the assumption that it is absent in
M. hyopneumoniae reasonable.
Our simulations show that a large part of the metabolic network
is not used for growth, in the simulated conditions, and as a result
many genes are predicted to be non-essential. This is an interesting
result as mycoplasma genomes are expected to be close to the
minimal gene set required for life without a host and therefore a
high percentage of genes were expected to be essential. Part of the
result can be explained because we applied a simpliﬁed biomass
equation, for example, addition of NADPH, FAD, and CoA to the
biomass equation added 5 essential genes, a 3.8% increase in the
percentage of essential genes (Table S7). Also our predictions for
gene essentiality were based on growth in complex medium while
conditions in the host will be different and gene essentiality might
be higher because nutrients are scarce. Though not all genes were
found to be essential, our transcriptomics dataset indicated that all
genes in the model were expressed and although the transcriptome
dataset collected is small, we identiﬁed a correlation between gene
expression and ﬂux for the glycerol uptake facilitor (glpF) and for
the glucose PTS transporter (MHP629) (Table S10).
Given the challenges associated with introducing genetic
modiﬁcation in M. hyopneumoniae, the potential of the described
knock-in mutants has to be carefully evaluated. Our model
predicted that both the introduction of a myo-inositol transporter
(single gene knock-in) as well as an arginine fermentation pathway
(5 gene knock-in) potentially increases the growth rate of mutant
strains.
To our knowledge, this is the ﬁrst study whereM. hyopneumoniae
growth is studied in controlled fermenter systems. In these
systems pH and oxygen concentration were controlled resulting in a
stabilized growth proﬁle and allowing accurate measurement of
growth rate, substrate uptake rates and by-product formationwhich
is essential data for model validation and parameterization. Our
stringent approach for model creation, applying annotation based
on functional protein domains, resulted in a more condensed model
of M. hyopneumoniae when compared to the reference model.
Following an iterative cycle of model driven experimentation, we
were able to double biomass production and reduce total process
time by pyruvate addition to aerobic fermentations, which
improved the economic potential of the production process. The
model we present provides a solid basis to understand the
metabolic capability ofM. hyopneumoniae and further optimize the
production process regarding biomass yield and process robust-
ness.
Nomenclature
CBM Constraint-based model
SBML Systems Biology Markup Language
COBRA Constraint Based Reconstruction and Analysis
DW Dry weight
BASH Bourne-again shell; Metabolite abbreviations are
explained in Table S11
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